Live Breaking News & Updates on Ionis Pharmaceuticals Price Performance

Stay updated with breaking news from Ionis pharmaceuticals price performance. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Ionis Pharmaceuticals, Inc. (NASDAQ:IONS) Receives Consensus Recommendation of "Moderate Buy" from Brokerages

Ionis Pharmaceuticals, Inc. (NASDAQ:IONS) Receives Consensus Recommendation of "Moderate Buy" from Brokerages
dailypolitical.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dailypolitical.com Daily Mail and Mail on Sunday newspapers.

United States , Joseph Baroldi , Pingora Partners , Royal Bank , Peoples Bank , Wolfe Research , Ionis Pharmaceuticals , News Ratings For Ionis Pharmaceuticals Daily , Mather Group , Securities Exchange Commission , Needham Company , Ionis Pharmaceuticals Inc , Analyst Recommendations For Ionis Pharmaceuticals , Ionis Pharmaceuticals Price Performance , Get Free Report , Exchange Commission , Director Joseph Klein , Valley Asset Management Partners , Get Free , Ionis Pharmaceuticals Daily ,

Ionis Pharmaceuticals (NASDAQ:IONS) Issues Earnings Results

Ionis Pharmaceuticals (NASDAQ:IONS) Issues Earnings Results
tickerreport.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tickerreport.com Daily Mail and Mail on Sunday newspapers.

United States , William Blair , Joseph Baroldi , Ionis Pharmaceuticals Inc , Earnings History For Ionis Pharmaceuticals , Securities Exchange Commission , Ionis Pharmaceuticals , Royal Bank , Jpmorgan Chase Co , Ionis Pharmaceuticals Price Performance , News Ratings For Ionis Pharmaceuticals Daily , Get Free Report , Director Joseph Klein , Exchange Commission , Ionis Pharmaceuticals Daily ,

Lisanti Capital Growth LLC Takes $3.16 Million Position in Ionis Pharmaceuticals, Inc. (NASDAQ:IONS)

Lisanti Capital Growth LLC purchased a new stake in Ionis Pharmaceuticals, Inc. (NASDAQ:IONS – Free Report) in the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor purchased 62,415 shares of the company’s stock, valued at approximately $3,158,000. Other institutional investors and hedge funds […] ....

United States , William Blair , Joseph Baroldi , Piper Sandler , Ionis Pharmaceuticals , Quarter For Ionis Pharmaceuticals , C Worldwide Group Holding , Wolfe Research , Securities Exchange Commission , Ionis Pharmaceuticals Price Performance , Associates Corp , Victory Capital Management Inc , T Bank Corp , News Ratings For Ionis Pharmaceuticals Daily , Ionis Pharmaceuticals Inc , Lisanti Capital Growth , Jpmorgan Chase Co , Ionis Pharmaceuticals Profile , Free Report , Capital Management , Get Free Report , Visit Holdingschannel , Ionis Pharmaceuticals Daily , Nasdaq Ions , Sec Filings , Hedge Fund Holdings ,

Privium Fund Management B.V. Has $10.36 Million Holdings in Ionis Pharmaceuticals, Inc. (NASDAQ:IONS)

Privium Fund Management B.V. Has $10.36 Million Holdings in Ionis Pharmaceuticals, Inc. (NASDAQ:IONS)
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

United States , C Frank Bennett , Piper Sandler , Eugene Schneider , Ionis Pharmaceuticals Company Profile , Exchange Commission , News Ratings For Ionis Pharmaceuticals Daily , Ionis Pharmaceuticals , Needham Company , Royal Bank , Almanack Investment Partners , Ionis Pharmaceuticals Inc , Quarter For Ionis Pharmaceuticals , Horizon Investments , Privium Fund Management , Ionis Pharmaceuticals Price Performance , Securities Exchange Commission , Peoples Bank , Goldman Sachs Group , Free Report , Investment Partners , Financial Advisors , Get Free Report , Frank Bennett , Visit Holdingschannel , Ionis Pharmaceuticals Daily ,

Ionis Pharmaceuticals (NASDAQ:IONS) Raised to Hold at StockNews.com

Ionis Pharmaceuticals (NASDAQ:IONS) Raised to Hold at StockNews.com
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

United States , Elizabethl Hougen , Stifel Nicolaus , Raymond James , William Blair , Analyst Recommendations For Ionis Pharmaceuticals , Insider Transactions At Ionis Pharmaceuticals , Goldman Sachs Group , Ionis Pharmaceuticals , Ionis Pharmaceuticals Company Profile , Securities Exchange Commission , Institutional Trading Of Ionis Pharmaceuticals , Xponance Inc , News Ratings For Ionis Pharmaceuticals Daily , Victory Capital Management Inc , Bleakley Financial Group , Ionis Pharmaceuticals Price Performance , Ionis Pharmaceuticals Inc , Free Report , Get Free Report , Exchange Commission , Financial Advisors , Financial Group , North Carolina , Victory Capital Management , Capital Management ,